MUMBAI, India, July 5 -- Intellectual Property India has published a patent application (202517060265 A) filed by Mirati Therapeutics, Inc., Princeton, U.S.A., on June 24, for 'processes and intermediates for synthesis of mrtx0902.'

Inventor(s) include Scattolin, Thomas; Chen, Cheng; and Achmatowicz, Michal.

The application for the patent was published on July 4, under issue no. 27/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to new synthetic routes of manufacturing MRTX0902. The invention also provides intermediates used in the provided synthetic routes, and the fumarate salt of MRTX0902."

The patent application was internationally filed on Nov. 16, 2023, under Internationa...